300239.SZ
东宝生物
SZSE · Healthcare · C 制造业 · CN
CNY 4.98
−5.50%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 54.41x
- PEG TTM
- 2.56x
- Price / book
- 1.71x
- Price / sales
- 4.04x
- Price / cash flow
- 18.38x
Enterprise value
- Enterprise value
- —
- EV / sales
- —
- EV / EBITDA
- —
- EV / EBIT
- —
- Market cap
- CNY 3.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026